Written by the Nuvirox Research Team
Key points
- Muscle mass declines slowly — roughly 0.4–0.5% a year in midlife — but strength falls two to five times faster.
- Loss of strength is a more consistent predictor of disability and death than loss of mass, which reframes what is worth measuring.
- Research on fatigability links lower skeletal muscle energetics to how effortful ordinary activity feels, independent of how much muscle you have.
Short answer: probably yes, in part — but it is the strength you are losing, not the bulk. Quantitative reviews of the aging literature find muscle mass declines at roughly 0.37–0.47% per year in midlife, while strength in the same people is lost two to five times faster. That divergence is why the stairs start feeling different before anything looks different in the mirror.
There is also a growing body of work on fatigability — how much effort a standardised task costs you — which turns out to track mitochondrial function in muscle, not just muscle size.
Figures from a quantitative review of longitudinal studies. Bar lengths are scaled for comparison, not plotted to an absolute axis.
Why does strength fall faster than mass?
Because muscle size is only one input into force production. Motor unit number declines with age, remaining motor units get remodelled, the nervous system's ability to fully recruit available fibres changes, and the quality of the tissue itself shifts as fat and connective tissue infiltrate.
Researchers use dynapenia for age-related strength loss specifically, distinguishing it from sarcopenia as mass loss. The distinction is not pedantic: studies that assessed both in the same people consistently found strength loss ran two to five times faster, and it was strength loss that predicted disability and mortality more reliably.
How does that translate into feeling tired?
Through the effort cost of ordinary activity. If your maximum has fallen, then carrying groceries, climbing a flight of stairs, or getting out of a low chair takes a higher percentage of what you have. The task did not change; your reserve did.
This is the concept behind perceived fatigability — fatigue anchored to a specific activity of specified intensity and duration, rather than a general question about how tired you feel. It is a more sensitive measure precisely because it controls for the fact that tired people do less.
Illustrative rather than plotted. The point is the narrowing gap between what daily tasks demand and what maximal capacity supplies — not any specific value.
What human studies actually show
The quantitative review is the anchor. Pooling longitudinal studies, median muscle mass loss was 0.47% per year in men and 0.37% per year in women. At age 75, mass was lost at 0.80–0.98% per year in men and 0.64–0.70% per year in women, while strength was lost at 3–4% per year in men and 2.5–3% per year in women. Studies measuring both in the same sample found strength loss two to five times faster than mass loss.
Muscle energetics track fatigability, not just size. Work within the Study of Muscle, Mobility and Aging measured maximal ATP production in vivo by phosphorus magnetic resonance spectroscopy and maximal oxidative phosphorylation ex vivo in permeabilised muscle fibres, then related both to perceived physical fatigability. Lower skeletal muscle energetics were associated with greater fatigability.
The picture extends beyond muscle. A study in the same cohort measured cerebral metabolic rate of oxygen by MRI in 119 older adults and related it to an accelerometry-based fatigability index derived from a fast-paced 400-metre walk, adjusting for skeletal muscle energetics and cardiorespiratory fitness. Fatigue in older adults appears to have both peripheral and central metabolic contributors.
The honest counterweight: direct measurement complicates the “strength falls much faster” story. Most of the evidence for that gap uses indirect proxies for muscle mass, such as lean mass from DXA. A study in the oldest old men using D3-creatine dilution — a direct measure of muscle mass — found declines over roughly six years of 12.8% in muscle mass and 15.1% in grip strength. Those are much closer together than the conventional two-to-five-fold gap implies.
And fatigability responds to intervention. A weight management intervention study measured perceived physical fatigability before and at 13 months. Scores fell by roughly 15%, and the proportion of participants in the higher-fatigability category dropped, alongside 6.2% body weight loss and a small increase in physical activity.
Study snapshot — the quantitative review
| Design | Quantitative review of cross-sectional and longitudinal studies |
| Key finding | Strength lost 2–5× faster than mass where both were measured |
| Rate at 75 | Strength: 3–4%/yr (men), 2.5–3%/yr (women) |
| Clinical relevance | Strength loss more consistently predicts disability and death than mass loss |
What building muscle won't fix
It will not resolve fatigue with a medical cause. Anaemia, thyroid disease, sleep apnoea, heart failure, kidney disease, depression, and a long list of medications all produce tiredness that resistance training does not touch. If your fatigue is new, worsening, or accompanied by breathlessness, weight change, or swelling, see a doctor.
It also will not happen quickly. Meaningful strength adaptations take weeks to months, and the neural component — better recruitment of what you already have — typically precedes any visible change in size.
And it is not the whole picture. The cerebral metabolic work suggests a central contribution to fatigability that muscle training alone would not address, and cardiorespiratory fitness is an independent contributor, as we discuss in the piece on low VO2 max.
What actually moves the needle
- Resistance training, progressively loaded. The only intervention with consistent evidence for reversing strength loss at any age. Two to three sessions a week, working the major movement patterns, is the standard prescription.
- Adequate protein, distributed across meals. Requirements appear higher in older adults than the general adult RDA — we go through that argument in the protein article.
- Aerobic work. Contributes to the energetics side and to cardiorespiratory fitness, both of which are independently associated with fatigability.
- Measuring something. Grip strength, five-times sit-to-stand, and usual walking speed are free, quick, and better validated as predictors than most things people pay to measure.
The measurement point is underrated. Grip strength and chair-stand performance are used in research precisely because they are sensitive and cheap, and tracking one of them twice a year tells you more about trajectory than most consumer panels.
Frequently asked questions
At what age does muscle loss start?
Declines are detectable from around the fourth decade, though they are slow at first. The rate accelerates after 70, and periods of illness or immobility can compress years of gradual loss into weeks.
Can you rebuild muscle after 60?
Yes. Resistance training produces strength and mass gains in older adults, including in the very old, though the rate of gain is typically slower than in younger people and adequate protein intake matters more.
Is grip strength really a good health marker?
It performs well in research as a predictor of disability and mortality, which is why it is embedded in sarcopenia criteria. It is a proxy for whole-body strength rather than a direct measure of it, so treat it as a signal rather than a diagnosis.
Does losing muscle affect metabolism enough to matter?
Muscle is metabolically active tissue and accounts for a large share of body mass, so losing it does reduce resting energy expenditure. The effect on how you feel day to day seems to run more through reduced functional reserve than through metabolic rate.
From Nuvirox
Why we formulated NAD+ Restore.
Every two-capsule serving delivers 500 mg of nicotinamide riboside chloride (NR) — one of the two most-researched NAD+ precursors, within the dose range used in published human trials.
It also includes 150 mg trans-resveratrol from Japanese knotweed and 50 mg quercetin from Sophora japonica — polyphenols studied alongside NAD+ pathways for cellular health support — plus 10 mg galactomannans from fenugreek to support absorption.
It ships with a 60-day money-back guarantee, which is long enough to actually evaluate it the way the research says you should.
The bottom line
If ordinary tasks have started to cost more than they used to, declining strength is a plausible part of the explanation and one of the few parts you can directly do something about. The research is clear that strength matters more than size for outcomes, that the energetics of muscle relate to how effortful activity feels, and that fatigability improves with intervention. It is also clear that persistent fatigue can have medical causes that training will not fix — get those ruled out first.
References
- Mitchell WK, Williams J, Atherton P, Larvin M, Lund J, Narici M. Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front Physiol. 2012;3:260. PMCID: PMC3429036.
- Walston JD. Sarcopenia in older adults. Curr Opin Rheumatol. 2012;24(6):623–627. PMCID: PMC4066461.
- Coen PM, Cawthon PM, Cummings SR, et al. Mitochondrial energetics and perceived physical fatigability severity in older adults (Study of Muscle, Mobility and Aging). PMCID: PMC10737726.
- Qiao Y, Coen PM, Cawthon PM, et al. Cerebral metabolic rate of oxygen and accelerometry-based fatigability in community-dwelling older adults. PMCID: PMC12341810.
- Cawthon PM, Orwoll ES, Ensrud KE, et al. Changes in D3Cr muscle mass, walking speed, grip strength, and chair stands performance in the oldest old men (MrOS). PMCID: PMC10737479.
- Glynn NW, Gmelin T, Renner SW, et al. Perceived physical fatigability improves after a weight management intervention. PMCID: PMC7742561.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.